EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CD44 Participates to Extramedullary Haematopoiesis Onset by Mediating the Interplay Between Monocytes and Haematopoietic Stem Cells in Myelofibrosis

Margherita Mirabile, Camilla Tombari, Anita Neroni, Lara Tavernari, Ruggiero Norfo, Elisa Bianchi, Monica Maccaferri, Barbara Mora, Sandra Parenti, Chiara Carretta, Matteo Bertesi, Marica Malerba und 13 weitere

Journal of Cellular and Molecular Medicine · 2025

DOI: 10.1111/jcmm.70720 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Margherita Mirabile und 24 weiteren Autor:innen. Beteiligte Einrichtung: Interdepartmental Centre for Stem Cells and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy. Hauptthemen laut MEDLINE: Hyaluronan Receptors, Primary Myelofibrosis, Monocytes, Hematopoiesis, Extramedullary. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Associazione Italiana per la Ricerca sul Cancro, Ministero dell'Istruzione, dell'Università e della Ricerca, NextGenerationEU.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extramedullary haematopoiesis (EMH) refers to blood generation outside of the bone marrow (BM). In Myelofibrosis (MF), a myeloproliferative neoplasm, the disruption of BM microenvironment promotes haematopoietic stem and progenitor cells (HSPCs) mobilisation, resulting in the onset of EMH in the spleen, and then in splenomegaly. Although JAK2 inhibitors have a good efficacy in reducing splenomegaly, the presence of a significant proportion of non‐responder patients underlines the need to explore the cellular mechanisms responsible for the EMH onset. In a MF mouse model, Ruxolitinib induces a reduction in spleen volume but does not affect EMH. CD44 inhibition successfully reduces monocyte and HSPC migration in an in vitro extravasation model. Strikingly, MF monocytes are more effective in promoting HSPC migration through the production of hyaluronic acid. Collectively, our results demonstrate that CD44 regulates the migration of monocytes that are crucial for the onset of EMH in MF patients, as they produce CD44 ligands recruiting HSPCs from the BM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyaluronan ReceptorsPrimary MyelofibrosisMonocytesHematopoiesis, ExtramedullaryHematopoietic Stem CellsAnimalsMiceHumansCell MovementNitrilesDisease Models, AnimalPyrimidinesMice, Inbred C57BLPyrazolesMaleBone Marrow

Stichwörter der Autor:innen

CD44cell migrationextramedullary haematopoiesishyaluronic acidmyelofibrosisosteopontin

Substanzen

Hyaluronan ReceptorsNitrilesruxolitinibPyrimidinesPyrazolesCD44 protein, human

Autor:innen und Institutionen

  • Interdepartmental Centre for Stem Cells and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy.
  • Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.
  • Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy.
  • Hematology Unit, Department Oncology and Hematology, Modena University Hospital, Modena, Italy.
  • Ospedale Maggiore Policlinico, Milan, Italy.
  • Pathology Unit, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy.

ORCID-Profile: Rossella Manfredini

Förderung

  • Associazione Italiana per la Ricerca sul Cancro
  • Ministero dell'Istruzione, dell'Università e della Ricerca
  • NextGenerationEU
  • Fondazione AIRC per la ricerca sul cancro ETS

Zitieren

APA

Mirabile, M., Tombari, C., Neroni, A., Tavernari, L., Norfo, R., Bianchi, E., Maccaferri, M., Mora, B., Parenti, S., Carretta, C., Bertesi, M., Malerba, M., Papa, E., Fabbiani, L., Bartalucci, N., Guglielmelli, P., Potenza, L., Losi, L., Passamonti, F., …, & MYNERVA (Myeloid NEoplasms Research Venture AIRC) investigators (2025). CD44 Participates to Extramedullary Haematopoiesis Onset by Mediating the Interplay Between Monocytes and Haematopoietic Stem Cells in Myelofibrosis. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70720

Vancouver

Mirabile M, Tombari C, Neroni A, Tavernari L, Norfo R, Bianchi E, et al. CD44 Participates to Extramedullary Haematopoiesis Onset by Mediating the Interplay Between Monocytes and Haematopoietic Stem Cells in Myelofibrosis. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70720

BibTeX
@article{Mirabile2025,
  author = {Mirabile, Margherita and Tombari, Camilla and Neroni, Anita and Tavernari, Lara and Norfo, Ruggiero and Bianchi, Elisa and Maccaferri, Monica and Mora, Barbara and Parenti, Sandra and Carretta, Chiara and Bertesi, Matteo and Malerba, Marica and Papa, Elisa and Fabbiani, Luca and Bartalucci, Niccolò and Guglielmelli, Paola and Potenza, Leonardo and Losi, Lorena and Passamonti, Francesco and Tagliafico, Enrico and Luppi, Mario and Rontauroli, Sebastiano and Vannucchi, Alessandro Maria and Manfredini, Rossella and MYNERVA (Myeloid NEoplasms Research Venture AIRC) investigators, MYNERVA (Myeloid NEoplasms Research Venture AIRC) investigators},
  title = {CD44 Participates to Extramedullary Haematopoiesis Onset by Mediating the Interplay Between Monocytes and Haematopoietic Stem Cells in Myelofibrosis},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2025},
  doi = {10.1111/jcmm.70720}
}
Kostenlos starten →